Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantation

Overview of attention for article published in International Journal of Hematology, September 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Readers on

mendeley: 32 Mendeley

Summary X

So far, Altmetric has seen 1 X post from an account with 14,948 followers.

Japanese study of risk of secondary primary malignancies (SPMs) in #myeloma patients with or without autologous stem cell transplantation finds survival benefit of receiving #Revlimid outweighed the increased risk of SPMs: https://t.co/dRGSVNkunN. https://

27 Sep 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.